🎉 M&A multiples are live!
Check it out!

SonoScape Valuation Multiples

Discover revenue and EBITDA valuation multiples for SonoScape and similar public comparables like Myomo, InfuSystem, and SmartVest.

SonoScape Overview

About SonoScape

Sonoscape Medical Corp is a Chinese manufacturer of medical devices for ultrasound diagnostic systems and transducers. The company's product categories include Ultrasound, Endoscope which also includes video equipment, and Electrocardiography consisting of veterinary ECG and resting ECG. Ultrasound category covers color Doppler trolley systems, color Doppler HCU, B/W trolley systems, and probe, among others. The organization has a business presence in China and in other countries.


Founded

2002

HQ

China
Employees

n/a

Website

sonoscape.com

Financials

LTM Revenue $292M

LTM EBITDA $35.1M

EV

$1.6B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

SonoScape Financials

SonoScape has a last 12-month revenue of $292M and a last 12-month EBITDA of $35.1M.

In the most recent fiscal year, SonoScape achieved revenue of $277M and an EBITDA of $29.3M.

SonoScape expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See SonoScape valuation multiples based on analyst estimates

SonoScape P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $292M $277M XXX XXX XXX
Gross Profit $162M $203M XXX XXX XXX
Gross Margin 56% 73% XXX XXX XXX
EBITDA $75.1M $29.3M XXX XXX XXX
EBITDA Margin 26% 11% XXX XXX XXX
Net Profit $51.0M $62.6M XXX XXX XXX
Net Margin 17% 23% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

SonoScape Stock Performance

As of April 15, 2025, SonoScape's stock price is CNY 31 (or $4).

SonoScape has current market cap of CNY 13.4B (or $1.8B), and EV of CNY 11.8B (or $1.6B).

See SonoScape trading valuation data

SonoScape Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$1.6B $1.8B XXX XXX XXX XXX $0.07

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

SonoScape Valuation Multiples

As of April 15, 2025, SonoScape has market cap of $1.8B and EV of $1.6B.

SonoScape's trades at 5.6x LTM EV/Revenue multiple, and 46.2x LTM EBITDA.

Analysts estimate SonoScape's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for SonoScape and 10K+ public comps

SonoScape Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $1.6B XXX XXX XXX
EV/Revenue 5.8x XXX XXX XXX
EV/EBITDA 55.3x XXX XXX XXX
P/E 94.2x XXX XXX XXX
P/E/Growth 1.1x XXX XXX XXX
EV/FCF 117.8x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get SonoScape Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

SonoScape Valuation Multiples

SonoScape's NTM/LTM revenue growth is 18%

SonoScape's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.

Over next 12 months, SonoScape's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate SonoScape's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for SonoScape and other 10K+ public comps

SonoScape Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth -5% XXX XXX XXX XXX
EBITDA Margin 11% XXX XXX XXX XXX
EBITDA Growth -61% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 28% XXX XXX XXX XXX
Revenue per Employee n/a XXX XXX XXX XXX
Opex per Employee n/a XXX XXX XXX XXX
S&M Expenses to Revenue 11% XXX XXX XXX XXX
G&A Expenses to Revenue 1% XXX XXX XXX XXX
R&D Expenses to Revenue 23% XXX XXX XXX XXX
Opex to Revenue 54% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

SonoScape Public Comps

See public comps and valuation multiples for Medical Devices and Medical Imaging & Diagnostics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Philips XXX XXX XXX XXX XXX XXX
Perspective Therapeutics XXX XXX XXX XXX XXX XXX
SmartVest XXX XXX XXX XXX XXX XXX
InfuSystem XXX XXX XXX XXX XXX XXX
Myomo XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

SonoScape M&A and Investment Activity

SonoScape acquired  XXX companies to date.

Last acquisition by SonoScape was  XXXXXXXX, XXXXX XXXXX XXXXXX . SonoScape acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by SonoScape

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About SonoScape

When was SonoScape founded? SonoScape was founded in 2002.
Where is SonoScape headquartered? SonoScape is headquartered in China.
Is SonoScape publicy listed? Yes, SonoScape is a public company listed on SHE.
What is the stock symbol of SonoScape? SonoScape trades under 300633 ticker.
When did SonoScape go public? SonoScape went public in 2017.
Who are competitors of SonoScape? Similar companies to SonoScape include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem.
What is the current market cap of SonoScape? SonoScape's current market cap is $1.8B
What is the current revenue of SonoScape? SonoScape's last 12-month revenue is $292M.
What is the current EBITDA of SonoScape? SonoScape's last 12-month EBITDA is $35.1M.
What is the current EV/Revenue multiple of SonoScape? Current revenue multiple of SonoScape is 5.6x.
What is the current EV/EBITDA multiple of SonoScape? Current EBITDA multiple of SonoScape is 46.2x.
What is the current revenue growth of SonoScape? SonoScape revenue growth between 2023 and 2024 was -5%.
Is SonoScape profitable? Yes, SonoScape is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.